Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This study investigates the use of methadone versus morphine wean for the treatment of
neonatal abstinence syndrome for infants exposed to opioids in utero. Half of infants who
require pharmacotherapy for NAS will receive a methadone wean, and half will receive a
morphine wean. Length of hospital stay, length of treatment and parent satisfaction will be
studied.